Mette Hjortkjær

Mette Hjortkjær is a Clinical Associate Professor at Aalborg University Hospital's Department of Gynaecology and Obstetrics within The Faculty of Medicine. Her research focuses on ovarian cancer biology, genetic factors influencing cancer progression, and novel therapeutic strategies involving PARP inhibitors and chemotherapy combinations. She has contributed to understanding the clinical significance of BRCAness and BRCA1 mutations in tumor prognosis.

Her work integrates molecular diagnostics (e.g., immunohistochemical detection of biomarkers) with clinical outcomes, particularly in platinum-resistant ovarian cancer cases. Key areas of expertise include homologous recombination deficiency analysis, Krukenberg tumor pathology, and treatment efficacy assessment in BRCA-negative patients.

Publications (2017–2019) demonstrate a consistent focus on translating molecular findings into clinical applications, with notable contributions to the International Journal of Gynecological Cancer and Cancer Treatment and Research Communications. Research has been cited 50+ times across Scopus and Mendeley. No awards explicitly listed but maintains active clinical and translational research roles in gynecological oncology.